nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—SRD5A1—polycystic ovary syndrome	0.848	1	CbGaD
Dutasteride—Finasteride—SRD5A1—polycystic ovary syndrome	0.00521	1	CrCbGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00297	0.0202	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00297	0.0202	CbGpPWpGaD
Dutasteride—SRD5A1—Androgen biosynthesis—POMC—polycystic ovary syndrome	0.0025	0.017	CbGpPWpGaD
Dutasteride—SRD5A2—Androgen biosynthesis—POMC—polycystic ovary syndrome	0.0025	0.017	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.00235	0.016	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.00235	0.016	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.00218	0.0148	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.00218	0.0148	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.00173	0.0117	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.00173	0.0117	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.00104	0.00706	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.00104	0.00706	CbGpPWpGaD
Dutasteride—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.000928	0.00631	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000671	0.00457	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000671	0.00457	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000531	0.00361	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000531	0.00361	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000531	0.00361	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000531	0.00361	CbGpPWpGaD
Dutasteride—CYP3A5—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000519	0.00353	CbGpPWpGaD
Dutasteride—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000516	0.00351	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000445	0.00302	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000445	0.00302	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000422	0.00287	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000402	0.00274	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000402	0.00274	CbGpPWpGaD
Dutasteride—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000397	0.0027	CbGpPWpGaD
Dutasteride—CYP3A5—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00037	0.00252	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000342	0.00233	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000342	0.00233	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000327	0.00222	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000327	0.00222	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000312	0.00212	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000312	0.00212	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000305	0.00207	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000305	0.00207	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000299	0.00203	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SUOX—polycystic ovary syndrome	0.000299	0.00203	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000299	0.00203	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SUOX—polycystic ovary syndrome	0.000299	0.00203	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000295	0.00201	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000295	0.00201	CbGpPWpGaD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000286	0.00194	CbGpPWpGaD
Dutasteride—CYP3A5—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000283	0.00193	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000278	0.00189	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000278	0.00189	CbGpPWpGaD
Dutasteride—CYP3A5—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000272	0.00185	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000272	0.00185	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000272	0.00185	CbGpPWpGaD
Dutasteride—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000261	0.00178	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000254	0.00172	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000254	0.00172	CbGpPWpGaD
Dutasteride—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000249	0.0017	CbGpPWpGaD
Dutasteride—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000241	0.00164	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000241	0.00164	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000241	0.00164	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000236	0.00161	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000236	0.00161	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TEAD2—polycystic ovary syndrome	0.000236	0.00161	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000236	0.00161	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000227	0.00155	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000227	0.00155	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000224	0.00152	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000224	0.00152	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000198	0.00135	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000198	0.00135	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000198	0.00135	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000196	0.00133	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000188	0.00128	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000186	0.00126	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000184	0.00125	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000182	0.00124	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—STAR—polycystic ovary syndrome	0.000179	0.00122	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—STAR—polycystic ovary syndrome	0.000179	0.00122	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000177	0.0012	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000177	0.0012	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000172	0.00117	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000161	0.00109	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HMMR—polycystic ovary syndrome	0.00016	0.00109	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HMMR—polycystic ovary syndrome	0.00016	0.00109	CbGpPWpGaD
Dutasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000157	0.00107	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000152	0.00104	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000152	0.00104	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000151	0.00102	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000151	0.00102	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000149	0.00102	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000146	0.000993	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000144	0.00098	CbGpPWpGaD
Dutasteride—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000143	0.000975	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000143	0.000971	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000143	0.000971	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—LHB—polycystic ovary syndrome	0.000139	0.000945	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—LHB—polycystic ovary syndrome	0.000139	0.000945	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000136	0.000923	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000136	0.000923	CbGpPWpGaD
Dutasteride—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000132	0.000896	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000131	0.000894	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000131	0.000894	CbGpPWpGaD
Dutasteride—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000127	0.000862	CbGpPWpGaD
Dutasteride—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000122	0.000828	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000121	0.000823	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000121	0.000823	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000118	0.000805	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000118	0.0008	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—RRM2—polycystic ovary syndrome	0.000117	0.000797	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—RRM2—polycystic ovary syndrome	0.000117	0.000797	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000116	0.00079	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—YAP1—polycystic ovary syndrome	0.000113	0.000768	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—YAP1—polycystic ovary syndrome	0.000113	0.000768	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NAMPT—polycystic ovary syndrome	0.000109	0.000738	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000109	0.000738	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000108	0.000734	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000108	0.000734	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000107	0.000729	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000107	0.000729	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000106	0.000724	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000106	0.000724	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000103	0.000703	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000101	0.000688	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000101	0.000688	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP17A1—polycystic ovary syndrome	9.96e-05	0.000678	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP17A1—polycystic ovary syndrome	9.96e-05	0.000678	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	9.64e-05	0.000656	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	9.54e-05	0.000649	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.51e-05	0.000647	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	9.22e-05	0.000627	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	9.1e-05	0.000619	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	8.77e-05	0.000597	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	8.64e-05	0.000588	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TH—polycystic ovary syndrome	8.62e-05	0.000586	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TH—polycystic ovary syndrome	8.62e-05	0.000586	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	8.57e-05	0.000583	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.54e-05	0.000581	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	8.46e-05	0.000575	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.42e-05	0.000573	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	8.39e-05	0.000571	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC2A4—polycystic ovary syndrome	8.39e-05	0.00057	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.39e-05	0.00057	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.96e-05	0.000541	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.94e-05	0.00054	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.88e-05	0.000536	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.88e-05	0.000536	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.83e-05	0.000533	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	7.48e-05	0.000509	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.11e-05	0.000484	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GNAS—polycystic ovary syndrome	7.04e-05	0.000479	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GNAS—polycystic ovary syndrome	7.04e-05	0.000479	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	6.95e-05	0.000473	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	6.78e-05	0.000461	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	6.76e-05	0.00046	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NCOR1—polycystic ovary syndrome	6.7e-05	0.000456	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NCOR1—polycystic ovary syndrome	6.7e-05	0.000456	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	6.7e-05	0.000455	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	6.51e-05	0.000443	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP1A1—polycystic ovary syndrome	6.35e-05	0.000432	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.35e-05	0.000432	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.28e-05	0.000427	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.2e-05	0.000422	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MTHFR—polycystic ovary syndrome	5.92e-05	0.000403	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—MTHFR—polycystic ovary syndrome	5.92e-05	0.000403	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	5.5e-05	0.000374	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	5.47e-05	0.000372	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	5.4e-05	0.000367	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.07e-05	0.000345	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5e-05	0.00034	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	4.8e-05	0.000327	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PPARG—polycystic ovary syndrome	4.8e-05	0.000327	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PPARG—polycystic ovary syndrome	4.8e-05	0.000327	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—POMC—polycystic ovary syndrome	4.74e-05	0.000322	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—POMC—polycystic ovary syndrome	4.74e-05	0.000322	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—INS—polycystic ovary syndrome	4.71e-05	0.00032	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—INS—polycystic ovary syndrome	4.71e-05	0.00032	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	4.48e-05	0.000305	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	4.46e-05	0.000303	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	4.43e-05	0.000302	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	4.42e-05	0.000301	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	4.08e-05	0.000277	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	4.08e-05	0.000277	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	4.08e-05	0.000277	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	3.97e-05	0.00027	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.92e-05	0.000266	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	3.79e-05	0.000258	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	3.78e-05	0.000257	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3.7e-05	0.000252	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	3.69e-05	0.000251	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	3.64e-05	0.000248	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	3.31e-05	0.000225	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	3.22e-05	0.000219	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	3.22e-05	0.000219	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.92e-05	0.000199	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.88e-05	0.000196	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	2.7e-05	0.000184	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	2.56e-05	0.000174	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	2.44e-05	0.000166	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.36e-05	0.00016	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.32e-05	0.000158	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	2.18e-05	0.000148	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	2.08e-05	0.000141	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.07e-05	0.000141	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.89e-05	0.000129	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.89e-05	0.000129	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	1.89e-05	0.000129	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	1.85e-05	0.000126	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	1.79e-05	0.000122	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.76e-05	0.00012	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.76e-05	0.000119	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	1.65e-05	0.000112	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	1.6e-05	0.000109	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	1.54e-05	0.000105	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.5e-05	0.000102	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.5e-05	0.000102	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	1.48e-05	0.000101	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	1.46e-05	9.94e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.38e-05	9.38e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.36e-05	9.24e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.26e-05	8.54e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.19e-05	8.09e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.18e-05	7.99e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.14e-05	7.78e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.14e-05	7.72e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.07e-05	7.31e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.01e-05	6.88e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.65e-06	6.56e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	9.59e-06	6.53e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	9.14e-06	6.22e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.8e-06	5.99e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	8.66e-06	5.89e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.6e-06	5.85e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.33e-06	5.67e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	8.08e-06	5.49e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.67e-06	5.22e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.43e-06	5.05e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.16e-06	4.87e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.88e-06	4.68e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.79e-06	4.62e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	6.55e-06	4.45e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	6.46e-06	4.39e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—INS—polycystic ovary syndrome	6.42e-06	4.37e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.41e-06	4.36e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.31e-06	4.29e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.46e-06	3.72e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.31e-06	3.61e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5e-06	3.4e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.46e-06	3.03e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.25e-06	2.89e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.03e-06	2.74e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.75e-06	2.55e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.04e-06	2.07e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3e-06	2.04e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.99e-06	2.03e-05	CbGpPWpGaD
